We are developing generative AI to support decision-making for healthcare professionals and the general public. Specifically, Cubec functions as a learning support tool that answers questions arising in physicians’ daily practice, and it generates revenue by providing pharmaceutical companies with high-precision data on physician needs. We are planning a phased business rollout, with the ultimate goal of implementing as a Software as a Medical Device (SaMD) that supports physicians’ clinical decision-making.
医師向け臨床ナレッジAI「Cubec」を開発する株式会社Cubec（本社：大阪府吹田市、代表取締役CEO：奥井 伸輔）は、2026年2月に「Cubec」のシステムアップデートを実施し、「高速・推論・論文」の3モードを搭載しま...
[画像1: https://prtimes.jp/i/124652/7/resize/d124652-7-ba24ae8e703572f504f9-4.png ] 臨床ナレッジAI「Cubec」を開発する株式会社Cubec（本社：大阪府吹田市、代表取締役CEO：奥井 伸輔）は、2025年12月4日に...
[画像: https://prtimes.jp/i/124652/6/resize/d124652-6-ae4e38298d8a616781ef-0.png ] 臨床ナレッジAI「Cubec」を開発する株式会社Cubec（本社：大阪府吹田市、代表取締役CEO：奥井 伸輔）は、京都キャピタルパ...
[画像1: https://prtimes.jp/i/124652/4/resize/d124652-4-50cff9910d0a18b51186-1.png ] 株式会社Cubec（本社：兵庫県神戸市東灘区、代表取締役CEO：奥井 伸輔）は、医師が抱える疑問に対し、信頼性の高い情報を...
[画像: https://prtimes.jp/i/124652/3/resize/d124652-3-2c0fd013495593c0dc10-0.jpg ] 写真提供：国立研究開発法人国立循環器病研究センター株式会社Cubec（以下、Cubec 本社：兵庫県神戸市東灘区、代表取締役...
Microsoft for Startups とは Microsoft for Startupsは、マイクロソフト社が世界140カ国以上にグローバル展開しているスタートアップ支援プログラムです。 革新的な技術やサービスを開発・提供をしているスタ...
[画像1: https://prtimes.jp/i/124652/1/resize/d124652-1-9de75484260b06329c8c-3.png ] 心不全患者が激増する「心不全パンデミック」 心不全は、心臓が全身に血液や酸素を送る「ポンプの機能」が働かなくな...
Development and sales of solutions for preventing the worsening of diabetes complications.
We are conducting clinical development of an oral therapeutic cancer vaccine. We have completed a Phase I clinical trial targeting urothelial carcinoma and are currently conducting a Phase I/IIa clinical trial for malignant pleural mesothelioma.
Cerebro Pharma was established in 2020 as an Osaka-based bio-venture with the mission to create a society free of dementia. We focus on research and development of healthcare products and pharmaceuticals specializing in the prevention and improvement of dementia and neurodegenerative diseases, and actively promote collaborative projects with major domestic pharmaceutical companies and academic institutions.
Our company engages in the research and development, manufacturing, and sales of diagnostic test kits, primarily focused on in vitro diagnostic (IVD) products. In the field of infectious diseases, we provide rapid diagnostic kits for tropical infectious diseases such as dengue fever. In the pre-symptomatic healthcare field, we offer testing solutions—including genetic testing and microbiological testing—for individual and corporate sales, as well as for medical and research institutions. In addition, we collaborate not only within Japan but also with overseas bases and partners, including those in Thailand, and have established a product development and supply system that complies with regulatory requirements in each country.
